Expression of prostate specific antigen in male breast cancer

P J Carder, V Speirs, J Ramsdale, M R J Lansdown

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Male breast cancer is uncommon, accounting for less than 1% of all breast cancers. Carcinoma metastatic to the male breast is also unusual, with metastatic prostatic carcinoma being among the most common primary sites from which such tumours derive. Metastatic prostatic cancer and primary breast cancer may be histologically indistinguishable without immunohistochemistry because both often infiltrate with a cribriform architecture. Distinguishing between primary and metastatic disease within the breast is important because the treatment options for each are radically different. Following a case in which metastatic prostatic disease was initially wrongly diagnosed as primary breast cancer, a small series of male breast cancers was examined for expression of prostate specific antigen (PSA) and prostatic acid phosphatase to assess the usefulness of these markers in making this distinction. Focal expression of PSA was found in one of 11 cases of male breast cancer. These results indicate that PSA should be used with caution in this context.

Original languageEnglish
Pages (from-to)69-71
Number of pages3
JournalJournal of Clinical Pathology
Volume58
Issue number1
DOIs
Publication statusPublished - Jan 2005

Fingerprint

Male Breast Neoplasms
Prostate-Specific Antigen
Breast Neoplasms
Prostatic Diseases
Carcinoma
Breast Diseases
Prostatic Neoplasms
Breast
Immunohistochemistry
Neoplasms

Keywords

  • Aged
  • Breast Neoplasms, Male
  • Diagnosis, Differential
  • Humans
  • Infant
  • Male
  • Middle Aged
  • Prostate-Specific Antigen
  • Prostatic Neoplasms
  • Case Reports
  • Letter

Cite this

Expression of prostate specific antigen in male breast cancer. / Carder, P J; Speirs, V; Ramsdale, J; Lansdown, M R J.

In: Journal of Clinical Pathology, Vol. 58, No. 1, 01.2005, p. 69-71.

Research output: Contribution to journalArticle

Carder, P J ; Speirs, V ; Ramsdale, J ; Lansdown, M R J. / Expression of prostate specific antigen in male breast cancer. In: Journal of Clinical Pathology. 2005 ; Vol. 58, No. 1. pp. 69-71.
@article{4be3271974ce42c6817c68ab319ae0e7,
title = "Expression of prostate specific antigen in male breast cancer",
abstract = "Male breast cancer is uncommon, accounting for less than 1{\%} of all breast cancers. Carcinoma metastatic to the male breast is also unusual, with metastatic prostatic carcinoma being among the most common primary sites from which such tumours derive. Metastatic prostatic cancer and primary breast cancer may be histologically indistinguishable without immunohistochemistry because both often infiltrate with a cribriform architecture. Distinguishing between primary and metastatic disease within the breast is important because the treatment options for each are radically different. Following a case in which metastatic prostatic disease was initially wrongly diagnosed as primary breast cancer, a small series of male breast cancers was examined for expression of prostate specific antigen (PSA) and prostatic acid phosphatase to assess the usefulness of these markers in making this distinction. Focal expression of PSA was found in one of 11 cases of male breast cancer. These results indicate that PSA should be used with caution in this context.",
keywords = "Aged, Breast Neoplasms, Male, Diagnosis, Differential, Humans, Infant, Male, Middle Aged, Prostate-Specific Antigen, Prostatic Neoplasms, Case Reports, Letter",
author = "Carder, {P J} and V Speirs and J Ramsdale and Lansdown, {M R J}",
year = "2005",
month = "1",
doi = "10.1136/jcp.2004.018291",
language = "English",
volume = "58",
pages = "69--71",
journal = "Journal of Clinical Pathology",
issn = "0021-9746",
publisher = "BMJ Publishing Group",
number = "1",

}

TY - JOUR

T1 - Expression of prostate specific antigen in male breast cancer

AU - Carder, P J

AU - Speirs, V

AU - Ramsdale, J

AU - Lansdown, M R J

PY - 2005/1

Y1 - 2005/1

N2 - Male breast cancer is uncommon, accounting for less than 1% of all breast cancers. Carcinoma metastatic to the male breast is also unusual, with metastatic prostatic carcinoma being among the most common primary sites from which such tumours derive. Metastatic prostatic cancer and primary breast cancer may be histologically indistinguishable without immunohistochemistry because both often infiltrate with a cribriform architecture. Distinguishing between primary and metastatic disease within the breast is important because the treatment options for each are radically different. Following a case in which metastatic prostatic disease was initially wrongly diagnosed as primary breast cancer, a small series of male breast cancers was examined for expression of prostate specific antigen (PSA) and prostatic acid phosphatase to assess the usefulness of these markers in making this distinction. Focal expression of PSA was found in one of 11 cases of male breast cancer. These results indicate that PSA should be used with caution in this context.

AB - Male breast cancer is uncommon, accounting for less than 1% of all breast cancers. Carcinoma metastatic to the male breast is also unusual, with metastatic prostatic carcinoma being among the most common primary sites from which such tumours derive. Metastatic prostatic cancer and primary breast cancer may be histologically indistinguishable without immunohistochemistry because both often infiltrate with a cribriform architecture. Distinguishing between primary and metastatic disease within the breast is important because the treatment options for each are radically different. Following a case in which metastatic prostatic disease was initially wrongly diagnosed as primary breast cancer, a small series of male breast cancers was examined for expression of prostate specific antigen (PSA) and prostatic acid phosphatase to assess the usefulness of these markers in making this distinction. Focal expression of PSA was found in one of 11 cases of male breast cancer. These results indicate that PSA should be used with caution in this context.

KW - Aged

KW - Breast Neoplasms, Male

KW - Diagnosis, Differential

KW - Humans

KW - Infant

KW - Male

KW - Middle Aged

KW - Prostate-Specific Antigen

KW - Prostatic Neoplasms

KW - Case Reports

KW - Letter

U2 - 10.1136/jcp.2004.018291

DO - 10.1136/jcp.2004.018291

M3 - Article

C2 - 15623486

VL - 58

SP - 69

EP - 71

JO - Journal of Clinical Pathology

JF - Journal of Clinical Pathology

SN - 0021-9746

IS - 1

ER -